Asclepius MedTech Limited

Revolutionising Pre- Operative Surgical Assessment by Unleashing and Unlocking the Power of Data

Our Mission is to improve the quality of life and outcomes for patients undergoing lower abdominal and orthopaedic surgeries, tackle the morbidity associated with these major surgeries and positively impact millions of patients’ lives. 

Delivering a sustainable, scalable and patient acceptable remote assessment model that will help hospitals transform how they perform surgical pre- operative surgical assessment and move it into the community.

Company Focus

Improving surgical outcomes and renewed focus on digital technologies to improve surgical pathways is priority for hospitals globally

Over 310 million major surgeries are performed each year with around 50 million in USA and 20 million in Europe and surgical demand is increasing due to the surge in multiple long-term conditions, earlier detection and an ageing population¹. The United Kingdom’s NHS round 5 million surgical procedures are performed each year².

During 2020-21 the number of NHS surgical procedures fell by 1.5 million due to the COVID pandemic, adding to the record high of 7.4 million people on NHS treatment waiting lists³. Over 410,000 people have been waiting more than 1 year for treatment in the UK, which is 265 times as many as compared to before the COVID pandemic, and this number is expected to rise⁴.

This challenge is repeated across the rest of Europe, Canada, USA and beyond. It will take many years to clear this backlog unless new solutions are found that increase the efficiency of surgical care pathways, particularly in pre-assessment to assess patient surgical fitness and plan their post surgical care.

Currently, there are no objective, precise, personalised and cost-effective assessment tools that combine real-time longitudinal physiological and functional capacity data sets for effective pre-operative risk stratification; instead methods reply on subjective ‘snapshot’ physical fitness data.

Surgical complications and readmissions post-surgery remain a key concern for surgical and clinical teams, estimating that 50% of post-operative complications are preventable¹.

In the UK the total cost to the NHS for re-admissions and treating complications is £13.7 billion⁴. Asclepius MedTech Ltd. estimates that if the NHS commissioned the Asclepius Platform the result would be a 25% reduction in readmissions saving the UK NHS £300M per year.

Reference

  1. Geoffrey P. Dobson. Trauma of major surgery: A global problem that is not going away. International Journal of Surgery Volume 81, September 2020, Pages 47-54
  2. Royal College of Surgeons of England: Surgery and the NHS in Numbers. [Most recent data 2013/14/15]
    https://www.rcseng.ac.uk/news-and-events/media-centre/media-background-briefings-and-statistics/surgery-and-the-nhs-in-numbers/
  3. Dobbs TD, Gibson JAG, Fowler AJ et al. Surgical activity in England and Wales during the COVID-19 pandemic: a nationwide observational cohort study. BJA 2021; 127: 196-204
    https://pubmed.ncbi.nlm.nih.gov/34148732/
  4. British Medical Association. NHS Backlog Data Analysis. Dec 2022.
    https://www.bma.org.uk/advice-and-support/nhs-delivery-and-workforce/pressures/nhs-backlog-data-analysis

Our Innovation

Surgfit© is the first remote patient assessment system for pre- operative surgical assessment

Remote 24/7 surgical pre- operative assessment alternative to in-hospital practice that provides pre- operative and surgical teams with comprehensive physiological and functional capacity reports to enhance shared decision-making, and improve patient stratification based on their ‘fitness for surgery’ and ‘complication risk’. 

Moreover, it has the potential to change the experience and surgical outcomes for patients. It is easy to implement and administer by pre- operative and surgical teams to remotely assess patients , predict surgical complications and plan their post operative recovery and discharge.

A Class IIa regulated sensor patch is worn on the chest to record physiological data about the patient’s fitness. This data is combined, with information from health questionnaires, is transmitted in real-time and visualised on the hospital pre- operative team’s clinical dashboard.

Analysis of these combined multimodal data sets means clinical teams can deliver safer and more effective surgical care, minimising the risk of complications, improving surgical efficiency and reducing readmissions. 

Patients experience better outcomes and earlier and safer discharge. Hospitals benefit from increased procedural efficiency and reduced costs with Surgfit© less impacted by workforce resource challenges.

Asclepius contributes to hospital’s ‘net zero’ by reducing reliance on clinic visits and patient care miles.

Image of Standard CPET Assessment

Company Status

Why we are investable

With significant funding from the National Institute of Health and Care Research (NIHR) and charitable bodies. Asclepius has undertaken proof-of-concept and quantitative studies to demonstrate the utility of the Asclepius Platform for patients and clinicians.

In collaboration with the NIHR Surgical Technologies MedTech Co-operative numerous PPIE and clinical expert focus groups have facilitated a deeper understanding of the barriers to implementation and scalability, and requirements to address patient acceptability.

In 2024, a large 200 patient observational clinical study to evaluate the Asclepius platform by surgical pre- operative teams to enhance clinical decision support, co-designed with PPIE, was completed. Our team is currently evaluating the trial results. 

Additional product development funding from the National Institute of Health and Care Research (NIHR) and investment from NLC European HealthTech Venture Builder facilitated upgrading our clinical dashboard, app interface with our regulated Class IIa sensor and the Asclepius App.

Surgfit© now offers hospitals the opportunity to transform how they perform surgical pre- operative assessment and move the service into the community.

Asclepius plans to integrate predictive software to improve patient flow, prioritise surgical lists, improve theatre scheduling and effect efficient discharge processes.

Surgfit© will launch in the UK 2025, followed by EU in 2026, and Canada and USA in 2027.

Our Partners

News from Asclepius Medtech

Contact Us

Become involved in our journey.

Please complete our contact form and we will be in touch shortly with Investor Information.

Please fill in the contact form and provide details of the scope of your research interest and we will be in touch shortly.

We are always interested to hear from patients to understand their views regarding our work and our technology. If you are willing to participate in patient research, please complete our contact form.